Law Firm News

---

Law Firm News

Firm Name

News Title

News

News Date

25383 matches |  6189-6195 displayed

1  881 882 883 884 885  3627

---

Debevoise & Plimpton, LLP

Le Cabinet D’avocats Debevoise & Plimpton LLP Nomme Drew Dutton En Qualité D’associé
Le cabinet d'avocats Debevoise & Plimpton LLP a le plaisir d’annoncer la nomination de Drew Dutton en qualité d’Associé.

« La nomination de Drew marque une étape importante et consolide le développement de notre bureau de Paris. Notre équipe renforce ainsi ses ressources pour offrir à nos clients une expertise de haut niveau dans les domaines essentiels des opérations de fusions / acquisitions et de marchés de capitaux » s’est félicité Raman Bet-Mansour, Managing Partner de Debevoise & Plimpton LLP en France.

Drew Dutton est né en 1969. Diplômé de l’Université de Harvard, de l’Université McGill où il a obtenu un LL.B en droit et de l’Université de Paris XI où il a obtenu un DESS. M. Dutton est avocat depuis 1997 et membre des barreaux de Paris, de New York et d’Angleterre et Pays de Galles.
M. Dutton a exercé successivement au sein de nos bureaux de New York, Francfort et de Paris au sein du département Corporate du cabinet. Il intervient principalement dans le cadre des fusions-acquisitions.

05-14-2007

---

Blank Rome LLP.

Firm Adds Experienced Government Regulation and Land Use Attorney to Real Estate Practice
Blank Rome announced today that Marvin B. Mitzner has joined the Firm as a partner in the real estate group. Mr. Mitzner brings over 20 years of experience to Blank Rome, specifically dealing in New York City land use and government regulation.

“The scope of Marvin’s experience in government regulation and land use will be a tremendous complement to Blank Rome’s nationally recognized real estate practice,” said Carl M. Buchholz, managing partner and chief executive officer. “We are pleased to welcome Marvin to Blank Rome and look forward to integrating his unique expertise into the Firm.”

Prior to joining Blank Rome, Mr. Mitzner served as a senior member (partner) in the New York office of Cozen O’Connor. Before joining Cozen O’Connor, he served as partner at the law firm of Fischbein Badillo Wagner Harding in New York and previously at Davidoff & Malito LLP. Mr. Mitzner has extensive experience representing developers, corporations, banks, and institutions in all aspects of land use and development law. He counsels clients in all facets of site development, including acquisition, zoning analysis, air rights purchases, landmarks law, environmental review, economic development and tax incentives, and discretionary land use approvals. Mr. Mitzner was liaison to the Board of Estimate on zoning matters and served as assistant corporation counsel of the City of New York in the division that handled and litigated most agency regulation and licensing matters.

In addition, Mr. Mitzner has prosecuted a wide range of applications before various New York City agencies involved in development, licensing, and government contracts, and has appeared at public hearings and before local community boards as part of the public review process. He has also represented clients before New York State and multi-jurisdictional agencies, such as the Metropolitan Transportation Authority (MTA), Division Housing and Community Renewal (DHCR), Empire State Development Corporation (ESDC), Department of Environmental Conservation (DEC), and the Port Authority of New York and New Jersey.

Mr. Mitzner received his law degree from New York Law School and a bachelor of science degree from City College of New York.

05-14-2007

---

Davis Polk & Wardwell

Morgan Stanley Emerging Markets Domestic Debt Fund Initial Public Offering
Davis Polk & Wardwell advised Morgan Stanley & Co. Incorporated in connection with the initial public offering by Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. of $1.275 billion of its shares of common stock. The fund is listed on the New York Stock Exchange under the symbol ‚EDD.?

The fund is advised by Morgan Stanley Investment Management Inc.

The Davis Polk corporate team included partners Joseph A. Hall and Winthrop B. Conrad Jr. and associates Ross A. Oliver and John T. Rudy. Associate Scott Hogan provided Investment Company Act advice. Counsel Mary Conway and associate Kimberly A. Champlin provided tax advice. The NASD team included counsel Marcie A. Goldstein and legal assistant Peggy A. Petercsak. All members of the Davis Polk team are based in the New York office.

05-14-2007

---

Davis Polk & Wardwell

Davis Polk Advises Smith & Nephew on Its Acquisition of Blue Sky Medical Group
Davis Polk & Wardwell advised Smith & Nephew plc on its acquisition of Blue Sky Medical Group Incorporated, a privately held medical device company that develops and manufactures products for treating chronic wounds using negative pressure wound therapy. Smith & Nephew is a global medical technology business, specializing in orthopedics, endoscopy and advanced wound management products.

In accordance with the terms of the merger agreement, Smith & Nephew purchased all of Blue Sky Medical Groups’ outstanding common stock for $15 million initially, with further milestone payments of up to $95 million related to revenues and other events. The transaction was signed on May 10, 2007, and closed on May 11, 2007.

The Davis Polk corporate team included partner Julia K. Cowles, associates Zachary R. Patton, Stephen Salmon and Tobias Bage (not admitted to practice in the United States) and legal assistant Cari M. Hebel. Partner Rachel D. Kleinberg provided tax advice. Counsel Cynthia Akard provided employment advice. All members of the Davis Polk team work in the Menlo Park office.

05-14-2007

---

Davis Polk & Wardwell

Davis Polk Advises Huntington Bancshares Incorporated on Its Offering of Trust Preferred Securities
Davis Polk & Wardwell advised Huntington Bancshares Incorporated on an SEC-registered offering of $250 million of 6.65% trust preferred securities by Huntington Capital III, a Delaware statutory trust and wholly owned subsidiary of Huntington Bancshares Incorporated, guaranteed on a subordinated basis by Huntington Bancshares Incorporated. The ‚hybrid? securities were structured as Moody’s Basket D securities, which provide Huntington Bancshares Incorporated with 75% equity credit and qualify as Tier 1 capital.

Huntington Bancshares Incorporated is a multi-state, diversified financial holding company headquartered in Columbus, Ohio. Through its subsidiaries, it provides full-service commercial and consumer banking services, mortgage banking services, automobile financing, equipment leasing, investment management, trust services, brokerage services, private mortgage insurance, reinsure credit life and disability insurance, and other insurance and financial products and services.

The Davis Polk corporate team included partner Luigi L. De Ghenghi, counsel Courtenay U. Myers and associates Pieter Weyts, Nadine M. Arendt and Joanna A. McGinley (not yet admitted). Erica Nuber was the legal assistant on the transaction. All members of the Davis Polk team are based in the New York office.

05-14-2007

---

Robinson & Cole LLP

Robinson & Cole Land Use Partner Addresses National American Planning Association
Robinson & Cole Land Use Partner Kenneth C. Baldwin recently spoke at the 2007 National American Planning Association Conference. He discussed legal issues and developing case law associated with the siting of wireless facilities.

05-14-2007

---

Paul, Hastings, Janofsky & Walker LLP

Paul Hastings Wins Patent Trial for Eisai Pharmaceuticals
Paul, Hastings, Janofsky & Walker LLP (Paul Hastings), a leading international law firm, won an important patent trial on behalf of Eisai Co. Ltd. regarding the pharmaceutical company's billion dollar a year stomach acid suppression medication, Aciphex.

Following a two week trial in March, the U.S. District Court in the Southern District of New York ruled Friday that Eisai's patent on Aciphex's active ingredient rabeprazole was enforceable - effectively defeating efforts by Teva Pharmaceuticals and Dr. Reddy's Laboratories to sell generic versions of the drug in the U.S. prior to the expiration of Eisai's patent in 2013.

The generic drugmakers had charged that Eisai's patent should be held unenforceable because Eisai had allegedly failed to disclose a copending patent application covering a drug molecule that was almost identical to the active ingredient of Aciphex. This failure was alleged to have been done with the intent to deceive the Patent Office.

Despite an earlier enforceability ruling by the Court, which was widely interpreted as leaning against Eisai's position and that spawned multiple class action antitrust lawsuits against Eisai, Paul Hastings attorneys convinced District Judge Gerard E. Lynch that although the compounds of the two patent applications were similar, they produced distinctly different effects. Judge Lynch also found Eisai's patent attorneys to be credible in their good faith explanations for their actions.

In October 2006, Paul Hastings had won a partial summary judgment for Eisai, upholding the validity of Aciphex's composition of matter patent. Eisai's patent is valid until May 8, 2013. With Friday's trial ruling, Paul Hastings ended more than three years of litigation and secured a total victory in this "bet your company" case for Eisai, which had a significant percentage of its company's revenues riding on the decision.

The Paul Hastings team was led by New York partners Joseph O'Malley and Bruce Wexler.

About Eisai Co., Ltd. Eisai Co., Ltd. is a research-based human health care company that discovers, develops and markets products throughout the world. Through a global network of research facilities, manufacturing sites and marketing subsidiaries, Eisai actively participates in all aspects of the worldwide health care system. Eisai employs more than 9,000 people worldwide.

About Paul Hastings' Litigation Department: The Paul Hastings Litigation Department provides premier litigation services to clients facing complex legal issues in the U.S., Europe, South America, the Middle East and Asia. With more than 300 lawyers in the Litigation Department, in addition to 200 litigators in the Employment Department, Paul Hastings is well positioned to handle all aspects of a client's litigation needs. Our sophisticated litigation practice covers every major practice including securities, intellectual property, class action and employment litigation, international arbitration, and white-collar crime. The Litigation Department has an impressive track record of winning large and difficult cases.

05-14-2007

---

25383 matches |  6189-6195 displayed

1  881 882 883 884 885  3627